References
- 1. McDonald LC, Killgore GE, Thompson A, Owens RC, Jr., Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005 Dec 8;353(23):2433-41.10.1056/NEJMoa051590
- 2. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005 Dec 8;353(23):2442-9.10.1056/NEJMoa051639
- 3. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005 Sep 24-30;366(9491):1079-84.10.1016/S0140-6736(05)67420-X
- 4. Kuehne SA, Collery MM, Kelly ML, Cartman ST, Cockayne A, Minton NP. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. J Infect Dis. 2014 Jan 1;209(1):83-6.10.1093/infdis/jit426386438623935202
- 5. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015 Feb 26;372(9):825-34.10.1056/NEJMoa140891325714160
- 6. Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013 Jul 22;173(14):1359-67.10.1001/jamainternmed.2013.705623780507
- 7. Kwon JH, Olsen MA, Dubberke ER. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am. 2015 Mar;29(1):123-34.10.1016/j.idc.2014.11.00325677706
- 8. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19;66(7):e1-e48.10.1093/cid/cix1085601898329462280
- 9. See I, Mu Y, Cohen J, Beldavs ZG, Winston LG, Dumyati G, et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis. 2014 May;58(10):1394-400.10.1093/cid/ciu125469792624604900
- 10. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis. 2012 Oct;55(8):1056-63.10.1093/cid/cis61422784871
- 11. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis. 2008 Nov 1;47(9):1162-70.10.1086/592257
- 12. Rafila A, Indra A, Popescu GA, Wewalka G, Allerberger F, Benea S, et al. Occurrence of Clostridium difficile infections due to PCR ribotype 027 in Bucharest, Romania. J Infect Dev Ctries. 2014 Jun 11;8(6):694-8.10.3855/jidc.4435
- 13. Popescu GA, Szekely E, Codiță I, Tălăpan D, Șerban R, Ruja G. Ghidul de diagnostic, tratament și prevenire a infecțiilor determinate de Clostridium difficile, ediția a 2-a. București, 2016.
- 14. Analiza evoluției infecției cu Clostridium difficile în spitalele din România. 2019 (cited 2019 August, 7); Available from: http://cnscbt.ro/index.php/analiza-date-supraveghere/infectii-nosocomiale-1/1225-analiza-evolutiei-infectiei-cu-clostridiumdifficile-in-spitalele-din-romania-2018/file.
- 15. Draganescu M, Baroiu N, Baroiu L, Diaconu C, Buzia OD. Efficeint Administration of Human Albumin in Clostridium Difficile Infection. Rev Chim. 2017 Mar;68(3):602-4.10.37358/RC.17.3.5510
- 16. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011 Jan 1;377(9759):63-73.10.1016/S0140-6736(10)61266-4
- 17. Kutty PK, Woods CW, Sena AC, Benoit SR, Naggie S, Frederick J, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis. 2010 Feb;16(2):197-204.10.3201/eid1602.090953295801220113547
- 18. Lessa FC. Community-associated Clostridium difficile infection: how real is it? Anaerobe. 2013 Dec;24:121-3.10.1016/j.anaerobe.2013.01.00623403280
- 19. Allard R, Dascal A, Camara B, Letourneau J, Valiquette L. Community-acquired Clostridium difficile-associated diarrhea, Montreal, 2005-2006: frequency estimates and their validity. Infect Control Hosp Epidemiol. 2011 Oct;32(10):1032-4.10.1086/66191121931255
- 20. Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L, Kennedy KJ, et al. Increasing incidence of Clostridium difficile infection, Australia, 2011-2012. Med J Aust. 2014 Mar 17;200(5):272-6.10.5694/mja13.1115324641152
- 21. Centrul National de Supraveghere si Control al Bolilor Transmisibile. (cited 2019 August 7); Available from: https://cnscbt.ro/.
- 22. Charlson Comorbidity Index (CCI). 2019 (cited 2019 August 7); Available from: https://www.mdcalc.com/charlson-comorbidity-index-cci.
- 23. ATLAS Score for Clostridium Difficile Infection. (cited 2019 August 7); Available from: https://www.mdcalc.com/atlas-score-clostridium-difficile-infection.
- 24. Infectious Diseases Society of America. ATLAS-A Bedside Scoring System Predicting Mortality Due to Clostridium Difficile Infection (CDI) in Elderly Hospitalized Patients. (cited 2019 August 7); Available from: https://idsa.confex.com/idsa/2010/webprogram/Paper4263.html.